JMJD2C Activators

The concept of JMJD2C Activators refers to compounds that indirectly influence the function of JMJD2C, a histone demethylase involved in epigenetic regulation of gene expression. Direct activation of JMJD2C through chemical means is not a well-established concept, as its modulation typically involves intricate cellular processes and interactions. However, targeting the broader epigenetic landscape or associated metabolic pathways offers potential strategies for indirectly influencing JMJD2C activity. Compounds such as IOX1, JIB-04, and ML324 are included for their role in inhibiting 2-oxoglutarate-dependent oxygenases and Jumonji demethylases, which may indirectly provide insights into JMJD2C's epigenetic regulatory function. GSK-J4 is a specific inhibitor of JMJD2C, and its effects on histone demethylation can indirectly inform about JMJD2C's biological roles.

Ascorbic acid, known as a cofactor for dioxygenases, could potentially modulate the enzymatic activity of JMJD2C. 2,4-Pyridinedicarboxylic acid and DMOG, by influencing 2OG-dependent oxygenases, might have an indirect impact on JMJD2C function. Tranylcypromine and Disulfiram are examples of compounds originally developed for other targets but found to influence histone demethylases, including those in the Jumonji C domain family. Methylstat, by targeting Jumonji C domain-containing demethylases, could also indirectly affect JMJD2C.Pyridostatin, a G-quadruplex stabilizer, represents an indirect approach to modulate gene expression, potentially influencing the epigenetic landscape where JMJD2C operates.